Chemomab Therapeutics Ltd. - CMMB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$602K
QoQ value delta ($000)
-$420K (-41.1%)
Implied price effect (QoQ)
-37.42%
Shares
Total shares
367,379
QoQ shares delta
-22,931 (-5.88%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CMMB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 171 103,781 0.0%
ADAR1 Capital Management, LLC 132 80,000 0.01%
KESTRA PRIVATE WEALTH SERVICES, LLC 85 51,710 0.0%
Ikarian Capital, LLC 85 51,793 0.01%
XTX Topco Ltd 31 19,013 0.0%
RHUMBLINE ADVISERS 29 17,856 0.0%
JANE STREET GROUP, LLC 25 15,598 0.0%
Virtu Financial LLC 18 10,933 0.0%
BNP PARIBAS FINANCIAL MARKETS 13 8,125 0.0%
MORGAN STANLEY 6 3,775 0.0%
GAMMA Investing LLC 4 2,514 0.0%
UBS Group AG 3 2,253 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0 2 0.0%
SBI Securities Co., Ltd. 0 26 0.0%